Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives. We are committed to creating an environment that supports great people and encourages them to support one another.

David Waterman

David Waterman

Scientist

What happens when you bring together brilliant, driven and creative minds hungry for innovation and discovery, equip them with the best gene editing technology available and tell them there are no limits? You cure diseases and improve the lives of countless people around the planet. I joined Prime Medicine to be a part of such a team bound by the goal of not just treating diseases but curing them.”

Chris Wilson

Chris Wilson

Scientist

In July of 2020, my mother passed away from malignant metastatic breast cancer. She was diagnosed six years prior for five of those six years, and she lived an everyday life thanks to taking part in 2 clinical trials. For the five years while on clinical trials, she was relatively devoid of side effects allowing her to live a mostly healthy life, which included seeing the birth of three grandchildren, volunteering at a local health clinic, and playing cards weekly with her closest friends. The last year of her life, she fought through chemotherapy and was marred by severe side effects until the disease spread to her brain, resulting in her death at home being cared for by loved ones. As someone who has been on the other side of the patient/researcher divide, I witnessed firsthand what the development of new therapies means to patients and their families. I joined Prime Medicine with the hopes of extending the lives and well-being of patients with genetic diseases through what I believe is the revolutionary technology of Prime Editing.”

Linghe Xi

Linghe Xi

Scientist

If you think applying Prime Editing, the fantastic technology with tremendous potential, to developing therapies against various types of diseases is already cool enough, I’d like to tell you that Prime Medicine offers more than that. It’s a warm family with great motivation, creativity and collaboration. Here we help each other to grow, and we are proud to show the world what we can do!”

career
opportunities

Research

Associate Director/Director, Clinical Biomarkers

view_

Research

Associate Director/Director of Viral Engineering Core

view_

Research

Associate Scientist, Pharmacology

view_

Technical Development & Operations

Associate Scientist/Senior Associate Scientist, Analytical Development

view_

Research

Director/Senior Director, Guide RNA Chemistry

view_

Research

Head of Compound and Sample Operations (Associate Director)

view_

G&A

Human Resources Business Partner (HRBP)

view_

Technical Development & Operations

Scientist I/II-Senior Scientist I/II, Oligonucleotide Chemistry

view_

Technical Development & Operations

Scientist II / Senior Scientist I, mRNA Analytical Development

view_

Research

Scientist/Manager, Flow Cytometry

view_

Research

Scientist/Senior Associate/Associate Scientist, Neuromuscular

view_

Research

Scientist/Senior Associate Scientist, Rare Genetic Lung Disease

view_

Research

Scientist, Vector Production

view_

G&A

Senior Accountant

view_

Technical Development & Operations

Senior Associate Scientist I / Scientist I, Analytical Development

view_

Technical Development & Operations

Senior Manager, External Manufacturing

view_

Technical Development & Operations

Senior Scientist CMC Process Development

view_

Technical Development & Operations

Senior/Scientist Engineer, mRNA Process Development

view_

Research

Senior Scientist II, Prime Editing Platform

view_

Spring 2023 Co-Op Program

Spring 2023 Co-op: Computational Sciences, Target ID and Algorithm Development

view_

Technical Development & Operations

Sr. Director, Head of CMC Portfolio Management & Cell Therapy Process Development

view_